Pharm-Olam and CATO-SMS have merged. Learn More
Check out our latest white paper! We partnered with Informa Pharma Intelligence to bring you the latest information on COVID-19 and its effect on the clinical landscape.
Cancer research has evolved exponentially over the last two centuries. The first time radiation was used to cure cancer...
Rare oncology is a subset of Oncology that encompasses those cancers with the rarest incidence. They may be a common type like...
There are more than 7,000 rare diseases in existence right now and together they impact millions of people around the world....
Tags: Rare & Orphan Disease
Rare disease isn’t rare. As a whole, more than 350 million people in the world have at least one rare disease – more than the...
COVID-19 moved from a ubiquitous virus to a full-on pandemic very quickly. As countries and city centers took steps to stem...
Rare disease drug development varies from the pathways seen in more established indications. The sample sizes are often...
In rare disease, every patient matters and it is important for CRO and sponsor medical staff to effectively monitor and...
Pharm-Olam is a clinical research organization (CRO) that has vast experience in rare diseases. To date, we have completed...
Subscribe to our blog and we'll give you our GDPR Controller & Processor Checklist.
